Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL6983856

O=S(=O)(O)C(F)(F)F.O=S(=O)(O)O

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Trifluoromethanesulfonic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA5A P35218 2/20 0.50
CA5B Q9Y2D0 2/20 0.50
ALDH1A1 P00352 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CA1 P00915 3/20 0.44
CA2 P00918 3/20 0.44
CA7 P43166 2/20 0.44
CA13 Q8N1Q1 1/20 0.44
TSHR P16473 3/20 0.43
TDP1 Q9NUW8 1/20 0.43
F2 P00734 1/20 0.36
PRSS1 P07477 1/20 0.36
PRSS2 P07478 1/20 0.36
PRSS3 P35030 1/20 0.36
NT5E P21589 1/20 0.33
CA4 P22748 1/20 0.33
CA6 P23280 1/20 0.33
CA9 Q16790 1/20 0.33
BLM P54132 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL28168879 0.96 CA5A (0.46) CA5ACA5BALDH1A1L3MBTL1CA1
Trifluoromethanesulfonic Acid SCHEMBL28128156 0.96 CA5A (0.46) CA5ACA5BALDH1A1L3MBTL1CA1
Trifluoromethanesulfonic Acid SCHEMBL28101503 0.96 CA5A (0.46) CA5ACA5BALDH1A1L3MBTL1CA1
Trifluoromethanesulfonic Acid SCHEMBL6288325 0.96 CA5A (0.46) CA5ACA5BALDH1A1L3MBTL1CA1
Trifluoromethanesulfonic Acid SCHEMBL15544820 0.96 CA5A (0.46) CA5ACA5BALDH1A1L3MBTL1CA1
Trifluoromethanesulfonic Acid SCHEMBL295 0.96
Trifluoromethanesulfonic Acid SCHEMBL39465 0.96 ALDH1A1 (0.50) CA5ACA5BALDH1A1L3MBTL1CA1
Trifluoromethanesulfonic Acid SCHEMBL3507077 0.96
Trifluoromethanesulfonic Acid SCHEMBL3950101 0.96
Trifluoromethanesulfonic Acid SCHEMBL25293989 0.92

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118239467-A Asphalt-based hard carbon material for negative electrode of sodium ion battery and preparation method thereof 湖南碳导新材料科技有限公司 2024-06-25 CN claimed
CN-107974280-A A kind of liquid acid alkylation reaction method 中国石油化工股份有限公司 2018-05-01 CN claimed
EP-1292269-A1 AGENT FOR DYEING KERATIN CONTAINING FIBERS Henkel Kommanditgesellschaft auf Aktien (DE) 2003-03-19 EP claimed
WO-2001097765-A1 AGENT FOR DYEING KERATIN CONTAINING FIBERS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2001-12-27 WO claimed
EP-0295050-B1 PROCESS FOR PREPARING A 4,4-DIPHENYLBUTANOIC ACID DERIVATIVE PFIZER INC. (US) 1991-04-17 EP claimed
EP-0295050-A1 Process for preparing a 4,4-diphenylbutanoic acid derivative PFIZER INC. (US) 1988-12-14 EP claimed
EP-3744756-B1 ACETOXY SYSTEMS EVONIK OPERATIONS GMBH (DE) 2024-07-03 EP disclosed
CN-112011054-B Acetoxygen systems 赢创运营有限公司 2023-09-29 CN disclosed
CN-114057182-B Method for dispersing nano material 中国科学院苏州纳米技术与纳米仿生研究所 2023-08-18 CN disclosed
CN-110139644-B Compositions and methods for treating insulin resistance 坦普尔大学 2023-05-23 CN disclosed
US-11596615-B2 Compositions and methods for treatment of insulin resistance Temple University—Of the Commonwealth System of Higher Education (US) 2023-03-07 US disclosed
CN-114369045-B Fluorine-containing alkylthio substituted olefin derivative and synthesis method thereof 中国科学院大连化学物理研究所 2022-10-21 CN disclosed
CN-114057182-A Method for dispersing nano material 中国科学院苏州纳米技术与纳米仿生研究所 2022-02-18 CN disclosed
WO-2019173633-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF INSULIN RESISTANCE TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2019-09-12 WO disclosed
WO-2019173640-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF INSULIN RESISTANCE TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2019-09-12 WO disclosed
CN-110139644-A For treating the composition and method of insulin resistance 坦普尔大学 2019-08-16 CN disclosed
US-20190192462-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF INSULIN RESISTANCE TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION 2019-06-27 US disclosed
CN-107974280-A A kind of liquid acid alkylation reaction method 中国石油化工股份有限公司 2018-05-01 CN disclosed
CN-103045156-A Carbon nanotube in situ reinforced LED packaging silica gel and preparation method thereof HANGZHOU ZFC NEW MATERIALS TECHNOLOGY CO LTD 2013-04-17 CN disclosed
CN-1953747-A Diphenyl-indol-2-on compounds and their use in the treatment of cancer TOPOTARGET AS (DK) 2007-04-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11596615-B2 Compositions and methods for treatment of insulin resistance GPR119, INSR, IAPP CA5A 1758/4885CA5B 1677/4885ALDH1A1 2926/4885
US-20190192462-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF INSULIN RESISTANCE GPR119, INSR, IAPP CA5A 1758/4885CA5B 1677/4885ALDH1A1 2926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.